Views & Analysis Solving the “information challenge” of rare disease diagnosi... Getting a diagnosis is often the biggest challenge facing a rare disease patient in the UK.
Views & Analysis Life sciences must become cloud-first to seize the science o... If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufa
Partner Content Partner Content Real-world evidence: breaking boundaries in rare disease The COVID-19 pandemic has added a new layer of complexity to the drug development process.
Views & Analysis A collaborative approach to greater diversity in clinical tr... The need for diversity in clinical trial populations has been a topic of discussion across regulators and the industry in general for decades.
Views & Analysis True patient-focused research through decentralised and hybr... How can pharma improve the patient-centricity of its trials during COVID-19 and beyond?
Views & Analysis Pharma’s digital transformation journey and the role of cust... Better management of customer data could help pharmaceutical companies’ digital transformation, according to Veeva’s Rebecca Silver.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
